Silo Pharma, Inc. (SILO) › Operating Cash FlowSilo Pharma, Inc. (SILO) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$46.3K2012: -$21.5K2013: -$181.6K2017: -$284.6K2018: $272.6K2019: -$794.3K2020: -$1.16M2021: -$2.28M2022: -$3.50M2023: -$3.22M2024: -$3.83M2025: -$4.66M-$4.66M2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$4.66M-21.6%2024-$3.83M-18.9%2023-$3.22M+7.8%2022-$3.50M-53.5%2021-$2.28M-96.9%2020-$1.16M-45.7%2019-$794.3K-391.3%2018$272.6K+195.8%2017-$284.6K—2013-$181.6K-745.8%2012-$21.5K+53.6%2011-$46.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share